Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Transplant Cell Ther. 2020 Oct 11;27(1):84.e1–84.e5. doi: 10.1016/j.bbmt.2020.10.008

Figure 4.

Figure 4.

NRM in the foscarnet group versus the no foscarnet group. The 6-month NRM was 4% in the foscarnet group (95% CI, 0 to 12%) and 18% in the control group (95% CI, 8% to 28%).